Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23146)

• Formulation Name: Edaravone 30 mg/100 ml Injection
• Company: Mitsubishi Tanabe Pharma America

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
MCI-186	(DM8ZHP1)	Amyotrophic lateral sclerosis	8B60.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Cysteine hydrochloride	(E00318)	25150	Antioxidant
Phosphoric acid	(E00039)	1004	Acidulant; Buffering agent
Sodium chloride	(E00077)	5234	Diluent; Tonicity agent
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Sodium sulhydrate	(E00549)	23665763	Antimicrobial preservative